Ashleigh Beiner-Murphy

London, ENG, United Kingdom

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 12 publications

A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

A short-acting psychedelic intervention for major depressive disorder: a phase IIa randomized placebo-controlled trial.

Journal: Nature medicine
Published: June 05, 2025

Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences.

Navigating groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences.

Journal: PloS one
Published: June 05, 2024

Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Effect of psilocybin versus escitalopram on depression symptom severity in patients with moderate-to-severe major depressive disorder: observational 6-month follow-up of a phase 2, double-blind, randomised, controlled trial.

Journal: EClinicalMedicine
Published: February 01, 2024

Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs.

Coming back together: a qualitative survey study of coping and support strategies used by people to cope with extended difficulties after the use of psychedelic drugs.

Journal: Frontiers in psychology
Published: January 12, 2024

Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.

Personality Change in a Trial of Psilocybin Therapy vs Escitalopram Treatment for Depression - CORRIGENDUM.

Journal: Psychological medicine
Published: July 19, 2023

Extended difficulties following the use of psychedelic drugs: A mixed methods study.

Extended difficulties following the use of psychedelic drugs: A mixed methods study.

Journal: PloS one
Published: July 14, 2023

When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.

When the Trial Ends: The Case for Post-Trial Provisions in Clinical Psychedelic Research.

Journal: Neuroethics
Published: June 16, 2023

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.

Personality change in a trial of psilocybin therapy v. escitalopram treatment for depression.

Journal: Psychological medicine
Published: June 02, 2023

ARC: a framework for access, reciprocity and conduct in psychedelic therapies.

ARC: a framework for access, reciprocity and conduct in psychedelic therapies.

Journal: Frontiers in psychology
Published: December 08, 2022

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Therapeutic Alliance and Rapport Modulate Responses to Psilocybin Assisted Therapy for Depression.

Journal: Frontiers in pharmacology
Published: October 01, 2021

Trial of Psilocybin versus Escitalopram for Depression.

Trial of Psilocybin versus Escitalopram for Depression.

Journal: The New England journal of medicine
Published: April 14, 2021

Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers.

Ayahuasca's 'afterglow': improved mindfulness and cognitive flexibility in ayahuasca drinkers.

Journal: Psychopharmacology
Published: July 05, 2019
Showing 1-12 of 12

Last Updated: 09/26/2026